Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04349059 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Primary completion date changed from estimate of Dec 2026 to Sep 17, 2026
Eligibility criteria expanded, about 23 words
Secondary endpoints: details revised at 3 of 3 entries
Study description expanded, about 15 words
Site details revised
Collaborators: 5 to 3
Publications: details revised at 17 of 17 entries
NotablePrimary endpoint(s) modified
Secondary endpoints revised (3)
v22
NotablePrimary and study completion dates: Dec 2025 to Dec 2026
Collaborators: 2 to 5
v21
NotablePrimary and study completion dates: Dec 2024 to Dec 2025v20
MinorStart date: Oct 2, 2023 to Oct 30, 2023v19
Show 17 earlier versionsHide 17 earlier versions
MinorStart date changed from estimate of Oct 2023 to Oct 2, 2023
Eligibility criteria expanded, about 106 words
v18
MinorStart date: Sep 2023 to Oct 2023v17
NotableTrial status: Not Yet Recruiting to Recruiting
Site details revised
v16
MinorRe-verified, no change to tracked fieldsv15
NotablePrimary endpoint revised
Secondary endpoints revised (3)
v14
MinorStart date: Aug 2023 to Sep 2023
Study description shortened, about 24 words
v13
NotableEnrollment target: 74 to 46v12Show 5 more changesShow less
Primary endpoints: 2 to 1
Start date: Jul 2023 to Aug 2023
Eligibility criteria expanded, about 177 words
Secondary endpoints: 2 to 3
Study description expanded, about 177 words
NotableStart date: May 15, 2023 to Jul 2023
Primary and study completion dates: Nov 15, 2024 to Dec 2024
v11
NotableStart date: Mar 15, 2023 to May 15, 2023
Primary and study completion dates: Sep 15, 2024 to Nov 15, 2024
v10
NotableStart date: Sep 15, 2022 to Mar 15, 2023v9
NotableStart date: Jul 15, 2022 to Sep 15, 2022v8Show 5 more changesShow less
Primary endpoints: 1 to 2
Primary and study completion dates: Jul 15, 2024 to Sep 15, 2024
Secondary endpoints: 3 to 2
Study description shortened, about 199 words
Eligibility criteria expanded, about 3 words
NotablePrimary and study completion dates: Jan 11, 2022 to Jul 15, 2024v7Show 4 more changesShow less
Start date: Jan 27, 2021 to Jul 15, 2022
Trial status: Active, Not Recruiting to Not Yet Recruiting
Eligibility criteria expanded, about 19 words
Study description expanded, about 58 words
MinorTrial status: Not Yet Recruiting to Active, Not Recruiting
Study sites: 0 to 1
Primary and study completion dates: Dec 2022 to Jan 11, 2022
Start date changed from estimate of May 2021 to Jan 27, 2021
v6
NotableStart date: Jan 2021 to May 2021v5
NotableStart date: Sep 2020 to Jan 2021
Primary and study completion dates: Sep 2022 to Dec 2022
v4
NotableStart date: Jun 2020 to Sep 2020v3
MinorRe-verified, no change to tracked fieldsv2
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.